• 1
    Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. JAMA. 1994; 271: 11631168.
  • 2
    Roohan PJ, Bickell NA, Baptiste MS, Therriault GD, Ferrara EP, Siu AL. Hospital volume differences and five-year survival from breast cancer. Am J Pub Health. 1998; 88: 454457.
  • 3
    Potosky AL, Merrill RM, Riley GF, et al. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst. 1997; 89: 16831691.
  • 4
    Chaudhry R, Goel V, Sawka C. Breast cancer survival by teaching status of the initial treating hospital. CMAJ. 2003; 164: 183188.
  • 5
    Mettlin CJ, Schoenfeld ER, Natarajan N, Suh O. Interhospital differences in cancer survival. J Chron Dis. 1987; 40: 157164.
  • 6
    Harcourt KF, Hicks KL. Is there a relationship between case volume and survival in breast cancer? Am J Surg. 2003; 185: 407410.
  • 7
    Tanaka H, Hiyama T, Hanai A, Fujimoto I. Interhospital differences in cancer survival: magnitude and trend in 1975–1987 in Osaka, Japan. Jpn J Cancer Res. 1994; 85: 680685.
  • 8
    Bonett A, Roder D, Esterman A. Case-survival rates for infiltrating ductal carcinomas by category of hospital at diagnosis in South Australia. Med J Aust. 1991; 154: 695697.
  • 9
    Richards MA, Wolfe CDA, Tilling K, Barton J, Bourne HM, Gregory WM. Variations in the management and survival of women under 50 years with breast cancer in the South East Thames region. Br J Cancer. 1996; 73: 751757.
  • 10
    Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995; 345: 12651270.
  • 11
    Twelves CJ, Thomson CS, Dewar JA, Brewster DH. Variation in the survival of women with breast cancer in Scotland. Br J Cancer. 1998; 78: 566571.
  • 12
    Stefoski Mikeljevic J, Haward RA, Johnston C, Sainsbury R, Forman D. Surgeon workload and survival from breast cancer. Br J Cancer. 2003; 89: 487491.
  • 13
    Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. Br Med J. 1996; 312: 145148.
  • 14
    Skinner KA, Helsper JT, Deapen D, Ye W, Sposto R. Breast cancer: do specialists make a difference? Ann Surg Oncol. 2003; 10: 606615.
  • 15
    Kingsmore D, Hole D, Gillis C. Why does specialist treatment of breast cancer improve survival? The role of surgical management. Br J Cancer. 2004; 90: 19201925.
  • 16
    Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000; 18: 23272340.
  • 17
    Hébert-Croteau N, Brisson J, Pineault R. Review of organizational factors related to care offered to women with breast cancer. Epidemiol Rev. 2000; 22: 228238.
  • 18
    Birkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002; 346: 11281137.
  • 19
    Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349: 21172227.
  • 20
    Ferguson B, Posnett J, Sheldon T. Concentration and choice in the provision of hospital services. CRD Report 8 (summary). NHS Centre for Reviews and Dissemination, York: University of York, 1997.
  • 21
    Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002; 137: 511520.
  • 22
    Smith TJ, Hillner BE, Bear HD. Taking action on the volume-quality relationship: how long can we hide our heads in the colostomy bag? J Natl Cancer Inst/ 2003; 95: 695697.
  • 23
    Birkmeyer NJO, Goodney PP, Stukel TA, Hillner BE, Birkmeyer JD. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer. 2005; 103; 435441.
  • 24
    Hébert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G. Compliance with consensus recommendations for treatment improves survival of women with node-negative breast cancer. J Clin Oncol. 2004; 22: 36853693.
  • 25
    Hébert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschênes L. Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ. 1999; 161: 951955.
  • 26
    Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613619.
  • 27
    National Institutes of Health. Treatment of early-stage breast cancer. NIH consensus conference. JAMA. 1991; 265: 391395.
  • 28
    Glick JH, Gelber RD, Goldhirsch A, Senn HJ. Meeting highlights: adjuvant therapy for primary breast cancer. J Natl Cancer Inst. 1992; 84: 14791485.
  • 29
    Kizer KW. The volume-outcome conundrum. N Engl J Med. 2003; 349: 21592161.
  • 30
    Chia SKL, Speers C, Kang A, et al. The impact of new chemotherapeutic and hormonal agents on the survival of women with metastatic breast cancer (MBC) in a population based cohort [abstract 22]. Proc Am Soc Clin Oncol. 2003; 22: 6.
  • 31
    Frelick RW. The Community Clinical Oncology Program (CCOP) story: review of community oncologists' experiences with clinical research trials in cancer with an emphasis on the CCOP of the National Cancer Institute between 1982 and 1987. J Clin Oncol. 1994; 12: 17181723.
  • 32
    Meyer AD, Tsui AS, Hinings CR. Configurational approaches to organizational analysis. Acad Manage J. 1993; 36: 11751195.
  • 33
    Lamarche PA, Beaulieu M-D, Pineault R, Contandriopoulos A-P, Denis J-L, Haggerty J. Choices for change: the path for restructuring primary healthcare services in Canada. CHSRF report, November 2003. Ottawa: Canadian Health Services Research Foundation, 2003.
  • 34
    Plsek PE. The challenge of complexity in health care. BMJ. 2001; 323: 625628.